We are live on ! Find out more
BFEC

Benjamin F. Edwards & Company Portfolio holdings

AUM $5.69B
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+15.37%
3 Year Est. Return
+19.73%
5 Year Est. Return
+83.07%
10 Year Est. Return
+162.03%
AUM
$1.42B
AUM Growth
+$143M
Cap. Flow
+$63.8M
Cap. Flow %
4.48%
Top 10 Hldgs %
18.7%
Holding
1,998
New
149
Increased
578
Reduced
484
Closed
112

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.88%
2 Technology 7.59%
3 Healthcare 6.04%
4 Industrials 5.35%
5 Financials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXUS icon
1001
Vanguard Total International Stock ETF
VXUS
$163B
$45K ﹤0.01%
800
-675
-46% -$36.3K
AMRN
1002
Amarin Corp
AMRN
$295M
$44K ﹤0.01%
104
FFTY icon
1003
CapForce IBD 50 ETF
FFTY
$78.6M
$44K ﹤0.01%
1,257
-20
-2% -$677
JAZZ icon
1004
Jazz Pharmaceuticals
JAZZ
$15.9B
$44K ﹤0.01%
294
-706
-71% -$96.1K
MDIV icon
1005
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$432M
$44K ﹤0.01%
2,340
-2,000
-46% -$36.9K
FIVE icon
1006
Five Below
FIVE
$13.4B
$43K ﹤0.01%
334
-26
-7% -$3.26K
FND icon
1007
Floor & Decor
FND
$5.64B
$43K ﹤0.01%
847
-51
-6% -$2.39K
GNTX icon
1008
Gentex
GNTX
$4.78B
$43K ﹤0.01%
1,474
+517
+54% +$14.6K
OTEX icon
1009
Open Text
OTEX
$6.08B
$43K ﹤0.01%
986
-36
-4% -$1.51K
KAMN
1010
DELISTED
Kaman Corp
KAMN
$43K ﹤0.01%
654
ABMD
1011
DELISTED
Abiomed Inc
ABMD
$43K ﹤0.01%
251
+217
+638% +$40.2K
BTO
1012
John Hancock Financial Opportunities Fund
BTO
$787M
$42K ﹤0.01%
1,165
+305
+35% +$10.4K
DSU icon
1013
BlackRock Debt Strategies Fund
DSU
$595M
$42K ﹤0.01%
3,794
-785
-17% -$8.52K
MPV
1014
Barings Participation Investors
MPV
$176M
$42K ﹤0.01%
2,612
+11
+0.4% +$181
QCLN icon
1015
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$572M
$42K ﹤0.01%
1,688
+3
+0.2% +$68
STM icon
1016
STMicroelectronics
STM
$44B
$42K ﹤0.01%
1,568
+3
+0.2% +$71
TSN icon
1017
Tyson Foods
TSN
$19.5B
$42K ﹤0.01%
461
WMB icon
1018
Williams Companies
WMB
$90.2B
$42K ﹤0.01%
1,752
-27
-2% -$618
LGND icon
1019
Ligand Pharmaceuticals
LGND
$5.59B
$41K ﹤0.01%
625
-32
-5% -$2.14K
MMD
1020
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$280M
$41K ﹤0.01%
1,962
+118
+6% +$2.46K
RCS
1021
PIMCO Strategic Income Fund
RCS
$248M
$41K ﹤0.01%
4,544
MRO
1022
DELISTED
Marathon Oil Corporation
MRO
$41K ﹤0.01%
3,001
+171
+6% +$2.08K
CPRT icon
1023
Copart
CPRT
$30.5B
$40K ﹤0.01%
1,780
+696
+64% +$14.9K
SMB icon
1024
VanEck Short Muni ETF
SMB
$318M
$40K ﹤0.01%
2,240
SR icon
1025
Spire
SR
$4.88B
$40K ﹤0.01%
480
+259
+117% +$21.2K

Similar funds

Benjamin F. Edwards & Company's Q4 2019 Portfolio in Review

As of Q4 2019, Benjamin F. Edwards & Company held 1,998 positions worth $1.42B, up 11% from $1.28B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Benjamin F. Edwards & Company deployed $63.8M of net new capital in Q4 2019, opening 149 new positions and adding to 578 existing holdings. Its largest new stake was Invesco S&P 500 Quality ETF: 247,238 shares worth $9.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares S&P Mid-Cap 400 Growth ETF, an estimated $22M trimmed.

  • Benjamin F. Edwards & Company's largest Q4 2019 buy was Invesco S&P 500 Quality ETF: 247,238 shares worth $9.04M.
  • Benjamin F. Edwards & Company added most to iShares Gold Trust in Q4 2019, an estimated $16.8M increase.
  • Benjamin F. Edwards & Company's biggest Q4 2019 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $22M.
  • Benjamin F. Edwards & Company fully exited iShares iBonds Dec 2019 Term Corporate ETF in Q4 2019, selling an estimated $4.45M.
  • Benjamin F. Edwards & Company's ten largest holdings make up 19% of its $1.42B portfolio in Q4 2019.
  • Benjamin F. Edwards & Company opened 149 new positions and closed 112 in Q4 2019.
  • Benjamin F. Edwards & Company's portfolio value rose 11% quarter-over-quarter to $1.42B.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2019, filed 6 Feb 2020.